Wells Fargo’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-948
Closed -$555K 7437
2022
Q3
$555K Hold
948
﹤0.01% 3633
2022
Q2
$517K Buy
948
+244
+35% +$123K ﹤0.01% 3723
2022
Q1
$446K Hold
704
﹤0.01% 4493
2021
Q4
$475K Buy
+704
New +$428K ﹤0.01% 4705

Other funds holding AGL

Wells Fargo's AGL Position: Q1 2026 in Review

Wells Fargo reduced its Agilon Health (AGL) stake by 66% in Q1 2026, selling an estimated $145K and leaving 4,528 shares worth $35.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5563.

Wells Fargo first reported a position in AGL in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.28M in Q2 2023. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Wells Fargo held 4,528 shares of Agilon Health worth $35.8K as of Q1 2026.
  • Wells Fargo sold 8,977 Agilon Health shares in Q1 2026, an estimated $145K.
  • Agilon Health made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5563 holding.
  • Wells Fargo first reported a position in Agilon Health in Q2 2021 and has held it in 20 quarters since.
  • Wells Fargo's Agilon Health position peaked at $1.28M in Q2 2023.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.